IP savvy capital for
early-stage
start-ups
Immetric Invest aims to make intellectual property as relevant to investment decisions as the revenue forecast.
Immetric Invest is an agile boutique investment fund dedicated to identifying, steering and growing high potential deep tech start-ups in Europe.
At Immetric Invest, we believe that the basis of any great idea and the great companies that grow from them, is held in the strength of its patents and patent strategy. By working at an operational level with our investment companies and using our extensive experience to build a bespoke and data driven IP strategy for them, we strongly increase their chances of success and high valuation for their shareholders.
We have been on the entire journey from foundation to IPO many times and it is this holistic view that allows us to help our investment companies develop an IP strategy that best protects the company’s assets and valuation most effectively.
Immetric Invest looks for…
…exciting technologies and for highly motivated leadership teams which are open and have an appetite for strategic intellectual property support, financial advice and strategic & commercialisation support.
We are looking to make investments in start-ups matching the following criteria:
Pre-seed and seed stage start-ups
European base
Primary R&D heavy technology ventures
Technology with patent opportunity in:
MedTech/Diagnostics
Consumer electronics
Robotics/Automation
Internet of Things
Transport
Renewables/clean tech
Appetite for strategic/business/engineering advice
Immetric Invest brings…
…seed capital and deep intellectual property expertise. We also offer hands-on support from proof of concept to IPO.
While a core pillar of Immetric Invest capabilities is based on IP know-how, the fund brings far more to the table for the companies & founders we invest in.
Beyond Seed Capital and IP, we offer access to an ecosystem of best-in-class services including:
Commercial/’Go-to-market’ strategy
Competitor monitoring
Technological expertise & problem-solving
Hands-on collaborative team mentoring
Strategic marketing
Financial ‘CFO’ oversight
Investor communications development
The Team
-
Dominic Davies
CEO and Investment Manager
Professional Qualifications
European Patent Attorney, Chartered UK Patent Attorney, Registered Design Attorney, European Trade Mark Attorney and Swedish Trade Mark Attorney
Start-up successes
Head of IP at FlatFrog Laboratories AB, Head of IP at Amniotics AB (due for IPO in 2021), Head of IP at Reccan Diagnostics (due for IPO in 2021), IP counsel for another 5+ start-ups.
Technical expertise
software, electronics, telecommunications, consumer products, MedTech, diagnostic platforms, cell therapy.
Degree
MEng in Information Systems Engineering at Imperial College London, UK
Experience
17 years spread between private practice and in-house in London and Sweden.
-
Andrew Stentiford
Investment Manager
Professional Qualifications
European Patent Attorney, Chartered UK Patent Attorney, Registered Design Attorney and Chartered UK Trade Mark Attorney.
Start-up successes
Extensive experience building up valuable IP portfolios for spin-outs at Maersk and start-ups across the Nordics.
Technical expertise
mechanical engineering, marine engineering, software, telecommunications, consumer products, MedTech, UAVs, robotics and automation.
Degree
MSci in Physics and Astronomy from Durham University, UK.
Experience
17 years spread between private practice and in-house in UK, Denmark and Sweden
Investment Partners
Immetric Invest is interested in hearing from potential investment partners, either Venture Capital or Venture Funds that:
Actively invest in the hard-tech/deep-tech space
Need IP support to complement their in-house expertise
Are looking for co-investment opportunities
Our Board of Directors
-
Anders Månsson
Board Director
Anders Månsson, BSc/MBA, has a strong background in the life science industry. He has held senior executive positions in large multinationals, at home and abroad, as well as leadership positions in smaller biotech companies, and he has served as an Industrial Advisor in the Life Science area to a multinational Private Equity company. Currently Mr. Månsson is CEO of RhoVac AB, Chairman of the Board of EQL Pharma AB, and Member of the Board of Amniotics AB.
-
Jenny Cummins
Board Director
Jenny has 16 years lifescience experience working with biotech, mid-sized & large pharma companies in business development, strategy and commercial teams. With a BSc in Biology from Imperial College, time spent in the UK government supporting Cambridge University spin-offs and several years as an analyst with McKinsey, she furthered her pharmaceutical career in companies such as Nycomed, Takeda, Cubist and Vifor Pharma, before founding her own company with the aim of bringing a management consulting approach to decision support.
-
Marcus Ulmefors
Board Director
Marcus Ulmefors (MEng Mechanical Engineering, Imperial College/UC Berkeley) has a background in renewable energy technologies (solar, wind, ocean waves) with specific experience in establishing and scaling data science capability. Focus is now directed towards Li-ion batteries, ranging from single-household off-grid products in East Africa to European gigascale manufacturing within Northvolt. He is an active investor in private and public engineering companies with primary expertise in electrification, manufacturing, software, and data.
-
Pam Stentiford
Chairperson
Pamela is a qualified management accountant with 13 years experience in UK Government Finance. She has managed a wide range of complex finance projects at a senior level and has a strong background in regional development, including major infrastructure projects and deal making with regional governments.
-
Dominic Davies
CEO and Board Member
Dominic is a European and UK Patent Attorney and has been Head of IP at FlatFrog Laboratories AB, Amniotics AB (IPO in 2021), Reccan Diagnostics (due for IPO in 2022), and IP counsel for another 5+ start-ups. Dominic obtained an MEng in Information Systems Engineering at Imperial College London and has 20 years of entrepreneurial and IP experience spread between London and Sweden.
[ɪ’metrɪk/]
What’s behind the name?
Our name captures the essence of what we do. ‘Immetric’ comes from the combination of immaterial assets (Intellectual Property, the great ideas and concepts developed by our companies) and metric (a system or standard of measurement). Immetric combines our ability to identify commercially viable & patentable ideas, measure and strategically grow those rights to increase the success & value of a company and its stakeholders.
Immetric Invest looks for exciting technologies and for highly motivated leadership teams behind those technologies. Our investments are made on the premise that these leadership teams will be open and have an appetite for strategic IP support, financial advice and strategic & commercialisation support based on their circumstances.
We approach these investments as hands-on partnerships that can be leveraged to drive long-term value and look for investors with a similarly collaborative outlook. This approach encompasses a proprietary holistic IP development strategy with an eye to risk reduction and IP storytelling.
From intellectual property strategy to crafting impactful IPO stories, we bring a wealth of experience to our investment teams.
Contact us.
If you are looking for capital for your IP-rich start-up and for help building out your IP into a valuable mature business, we would love to hear from you.